Abel Hall LLC acquired a new stake in abrdn Healthcare Investors (NYSE:HQH - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 33,000 shares of the financial services provider's stock, valued at approximately $511,000. Abel Hall LLC owned 0.06% of abrdn Healthcare Investors at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently modified their holdings of the company. Ameritas Advisory Services LLC bought a new position in shares of abrdn Healthcare Investors in the 2nd quarter valued at about $96,000. Janney Montgomery Scott LLC boosted its holdings in shares of abrdn Healthcare Investors by 0.5% during the 2nd quarter. Janney Montgomery Scott LLC now owns 156,361 shares of the financial services provider's stock worth $2,422,000 after buying an additional 768 shares during the period. Goldman Sachs Group Inc. boosted its holdings in shares of abrdn Healthcare Investors by 7.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 11,732 shares of the financial services provider's stock worth $191,000 after buying an additional 788 shares during the period. Smith Asset Management Co. LLC bought a new stake in shares of abrdn Healthcare Investors during the 1st quarter worth about $1,961,000. Finally, Needham Investment Management LLC boosted its holdings in shares of abrdn Healthcare Investors by 3.7% during the 1st quarter. Needham Investment Management LLC now owns 264,473 shares of the financial services provider's stock worth $4,295,000 after buying an additional 9,395 shares during the period. Institutional investors own 32.60% of the company's stock.
abrdn Healthcare Investors Stock Up 0.9%
Shares of HQH stock opened at $18.54 on Wednesday. The company has a 50-day simple moving average of $16.73 and a 200 day simple moving average of $16.00. abrdn Healthcare Investors has a 52 week low of $13.77 and a 52 week high of $18.86.
abrdn Healthcare Investors Cuts Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Friday, August 22nd were issued a dividend of $0.51 per share. The ex-dividend date of this dividend was Friday, August 22nd. This represents a $2.04 annualized dividend and a dividend yield of 11.0%.
abrdn Healthcare Investors Company Profile
(
Free Report)
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider abrdn Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.
While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.